Avadel pharmaceuticals to provide a corporate update and report first quarter 2025 financial results on may 7

Dublin, ireland, april 30, 2025 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:00 a.m. et on wednesday, may 7, 2025, to provide a corporate update and discuss the company's financial results for the first quarter ended march 31, 2025.
AVDL Ratings Summary
AVDL Quant Ranking